Reviewing Arena Pharmaceuticals


Arena Pharmaceuticals and GenVec are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation. 46.2% of Arena Pharmaceuticals shares are held by institutional investors.



from Biotech News